BCL2 and acute lymphoblastic leukemia: Holz et al., investigating the effects of combined BCL-2 and PI3K/Akt inhibition by perifosine and venetoclax, respectively, observed a synergistic action on different points of the apoptotic process and an antileukemic activity in B-ALL cell lines [58].